3.2.1.103 A1-glycolipid + H2O - ? - ? 139842 3.2.1.103 Ab-glycolipid + H2O - ? - ? 139843 3.2.1.103 erythroglycan + H2O - ? - ? 139833 3.2.1.103 Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc + H2O - ? - ? 139825 3.2.1.103 Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc-Cer + H2O - Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Gal + Glc-Cer - ? 139824 3.2.1.103 Gal(beta1-4)GlcNAc(beta1-3)Gal(beta1-4)sorbitol + H2O - Gal(beta1-4)GlcNAc(beta1-3)Gal + sorbitol - ? 139819 3.2.1.103 Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-Cer + H2O - ? - ? 139820 3.2.1.103 Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-Cer + H2O no activity ? - ? 139820 3.2.1.103 Galbeta1-3GlcNAc(6-2alphaNeuAc)beta1-3Galbeta1-4Glc + H2O - ? - ? 139832 3.2.1.103 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc + H2O - ? - ? 139829 3.2.1.103 Galbeta1-3[Fucalpha1-4]GlcNAcbeta1-3Galbeta1-4Glc + H2O - ? - ? 139827 3.2.1.103 Galbeta1-3[Fucalpha1-4]GlcNAcbeta1-3Galbeta1-4Glc-Cer + H2O - Galbeta1-3[Fucalpha1-4]GlcNAcbeta1-3Gal + Glc-Cer - ? 139826 3.2.1.103 Galbeta1-4GlcNAcbeta1-3Galbeta1-3Galbeta1-4Glc-Cer + H2O - Galbeta1-4GlcNAcbeta1-3Galbeta1-3Gal + Glc-Cer - ? 139823 3.2.1.103 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc + H2O - ? - ? 139828 3.2.1.103 glycosphingolipids + H2O lacto-N-glycosylceramide series having the common structure R-GlcAcbeta1-3Galbeta1-4Glc(or GlcNAc) are hydrolyzed at Galbeta1-4Glc (or GlcNAC) linkages. beta-Galactosyl linkages in globo series or ganglio series of glycolipids are not hydrolyzed ? - ? 139836 3.2.1.103 H1-glycolipid + H2O - ? - ? 139840 3.2.1.103 keratan sulfate + H2O - keratan oligosaccharides 6-O-sulfo-GlcNAcbeta1-3Gal is the major product ? 139815 3.2.1.103 keratan sulfate + H2O - keratan oligosaccharides 2-acetamido-2-deoxy-6-O-sulfo-beta-D-Gal-(1-3)-D-Gal + 2-acetamido-2-deoxy-6-O-sulfo-beta-D-Glc-(1-3)-6-O-sulfoD-Gal-(1-4)-2-acetamido-2-deoxy-6-O-sulfo-beta-D-Glc-(1-3)-D-Gal ? 139815 3.2.1.103 keratan sulfate + H2O from bovine cornea keratan oligosaccharides more than 75% of the oligosaccharides are sulfated unbranched poly(N-acetyllactosamine) sequences, (-3/4GlcNAcbeta1-3Galbeta1-)n. SO3-beta1-3Gal accounts for almost 35% of the oligosaccharide material while 40% consists of four oligosaccharides, unbranched tetrasaccharides, hexasaccharides, octasaccharides and decasaccharides of poly(N-acetyllactosamine)type, having 3, 5, 7 and 9 sulfate residues respectively. A sulfate residue is attached to the C6 position of each N-acetylglucosamine and each internal galactose residue of the four oligosaccharides ? 139815 3.2.1.103 keratan sulfate + H2O from bovine cornea keratan oligosaccharides GlcNAcbeta1-3Gal + sulfated disaccharides, trisaccharides, tetrasaccharides, hexasaccharides, octasaccharides and decasaccharides based on the sequence (-3/4GlcNAcbeta1-3Galbeta1-), having 1, 3, 5, 7 and 9 sulfate groups ? 139815 3.2.1.103 keratan sulfate + H2O from teleost skin keratan oligosaccharides no production of GlcNAcbeta1-3Gal ? 139815 3.2.1.103 keratan sulfate + H2O from teleost skin keratan oligosaccharides 6-O-sulfo-GlcNAcbeta1-3Gal is one of the major products ? 139815 3.2.1.103 keratan sulfate + H2O from teleost skin keratan oligosaccharides GlcNAcbeta1-3Gal ? 139815 3.2.1.103 keratan sulfate + H2O keratan sulfate chains from bovine articular cartilage. Presence of fucose on N-acetylglucosamine residues in keratan sulfates protects both of the adjacent unsulfated galactose residues from keratanase cleavage keratan oligosaccharides GlcNAc(6S)beta1-3Galbeta1-4(Fucalpha1-3)GlcNAc(6S)beta1-3Galbeta1-4GlcNAc(6S)beta1-3Gal-ol + GlcNAc(6S)beta1-3Galbeta1-4(Fucalpha-3)GlcNAc(6S)beta1-3Galbeta1-4GlcNAc(6S)beta1-6(Galbeta1-33)GalNAc-ol ? 139815 3.2.1.103 keratan sulfate + H2O - keratan oligosaccharides - ? 139815 3.2.1.103 keratan sulfate + H2O from nasal carilage keratan oligosaccharides - ? 139815 3.2.1.103 keratan sulfate + H2O from bovine cornea keratan oligosaccharides - ? 139815 3.2.1.103 lacto-N-fucopentaose I + H2O - ? - ? 139839 3.2.1.103 lacto-N-fucopentaose II + H2O - ? - ? 139844 3.2.1.103 lacto-N-fucopentaose III + H2O - ? - ? 139845 3.2.1.103 lacto-N-neotetraosylceramide + H2O - ? - ? 139846 3.2.1.103 lacto-N-tetraitol + H2O - sorbitol + Galbeta(1-3)GlcNAcbeta(1-3)Gal - ? 139818 3.2.1.103 lacto-N-tetraose + H2O - glucose + Galbeta(1-3)GlcNAcbeta(1-3)Gal - ? 139817 3.2.1.103 lacto-N-tetraose + H2O - ? - ? 139837 3.2.1.103 additional information sialosyl substitution at the terminal galactosyl residue of lacto-N-neotetraosyl structure of paragloboside greatly enhances the hydrolyzability of the internal Galbeta1-4Glc linkage, thus producing a high yield of sialotetrasaccharide (AcNeualpha2-3Galbeta1-4GlcNAcbeta-3Gal). The Galbeta1-4GlcNAc linkage located in the middle of the repeating Galbeta1-4GlcNAc(or Glc) unit seen in H2-glycolipid or Ab-glycolipid, (R-Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-Cer) is preferentially hydrolyzed relative to the Galbeta1-4Glc linkage directly attached to ceramide. The branched structure as is found in H3-glycolipid greatly reduces the hydrolyzability ? - ? 89 3.2.1.103 additional information hydrolyzes glycoconjugates containing N-acetyllactosamine repeating units ? - ? 89 3.2.1.103 additional information hydrolyzes the type 2 sequence Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc at about twice the rate of the type 1 isomer, Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc ? - ? 89 3.2.1.103 additional information AB active blood group substance can be hydrolyzed only after Smith degradation ? - ? 89 3.2.1.103 additional information no activity with Galbeta1-4GlcNAcbeta1-6Galbeta1-4GlcNAcbeta1-6(Galbeta1-3)GalNAc-ol ? - ? 89 3.2.1.103 additional information induced with high efficiency in culture medium containing Smith-degraded gastric mucin ? - ? 89 3.2.1.103 additional information the enzyme is produced without induction by keratan sulfate ? - ? 89 3.2.1.103 mucin + H2O desialyzed pig colonic mucin GlcNAcbeta(1-3)Gal + GlcNAc-6Sbeta(1-3)Gal + resistant polymer - ? 139816 3.2.1.103 neolacto-type glycosphingolipid + H2O hydrolysis of the internal beta1,4-galactosyl linkage of various neolacto-type glycosphingolipids to produce glucosylceramides glucosylceramide + ? - ? 139835 3.2.1.103 NeuAcalpha2-3Galbeta1-3GlcNAc(6-2alphaNeuAc)beta1-3Galbeta1-4Glc + H2O - ? - ? 139830 3.2.1.103 NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-Cer + H2O - NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Gal + Glc-Cer - ? 139821 3.2.1.103 NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-4Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc-Cer + H2O - NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-4Galbeta1-3GlcNAcbeta1-3Gal + Glc-Cer - ? 139822 3.2.1.103 NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-4Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc-Cer + H2O no activity NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-4Galbeta1-3GlcNAcbeta1-3Gal + Glc-Cer - ? 139822 3.2.1.103 NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc + H2O - ? - ? 139831 3.2.1.103 paragloboside + H2O - ? - ? 139838 3.2.1.103 polyglycosylceramides + H2O in absence of sodium taurodeoxycholate conversion into at least three shorter-chain glycosphingolipids, in presence of sodium taurodeoxycholate conversion into glucosylceramide ? in absence of sodium taurodeoxycholate conversion into at least three shorter-chain glycosphingolipids, in presence of sodium taurodeoxycholate conversion into glucosylceramide ? 139834 3.2.1.103 sialosylparagloboside + H2O - ? - ? 139841 3.2.1.103 sulfated glycosaminoglycan + H2O pH 6.8 N-acetyl-D-glucosamine-6-sulfate + ? - ? 406720